SEC CIK 1621241
Farkas K Christopher
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CWview stock → | 4,274 | 2026-07-06 |
Position History — CW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-06 | Grant / award | 21 | $634.88 | 4,274 |
| 2026-03-18 | Open-market sale | 1,265 | $689.69 | 4,253 |
| 2026-03-17 | Open-market sale | 918 | $677.46 | 5,518 |
| 2026-03-16 | Option exercise (derivative) | 2,183 | $0.00 | 9,366 |
| 2026-03-16 | Option exercise | 2,183 | $0.00 | 6,436 |
| 2026-03-09 | Grant / award (derivative) | 645 | $0.00 | 11,549 |
| 2026-02-18 | Open-market sale | 3,105 | $694.51 | 4,253 |
| 2026-02-04 | Open-market sale | 2,665 | $626.33 | 7,358 |
| 2026-02-03 | Grant / award | 5,770 | $674.32 | 10,023 |
| 2026-01-05 | Grant / award | 17 | $472.17 | 4,253 |
| 2025-11-11 | Open-market sale | 5,047 | $577.91 | 4,236 |
| 2025-07-02 | Grant / award | 30 | $414.23 | 9,283 |
| 2025-05-01 | Open-market sale | 4,780 | $350.00 | 9,253 |
| 2025-03-18 | Open-market sale | 922 | $325.47 | 14,033 |
| 2025-03-17 | Option exercise (derivative) | 2,243 | $0.00 | 10,894 |
| 2025-03-17 | Option exercise | 2,243 | $0.00 | 14,955 |
| 2025-03-10 | Grant / award (derivative) | 1,451 | $0.00 | 13,137 |
| 2025-02-05 | Open-market sale | 2,453 | $347.00 | 12,712 |
| 2025-02-04 | Grant / award | 5,912 | $344.57 | 15,165 |
| 2025-01-06 | Open-market buy | 30 | $304.12 | 9,253 |
| 2024-07-03 | Open-market buy | 51 | $232.62 | 9,223 |
| 2024-03-20 | Open-market sale | 880 | $244.20 | 9,172 |
| 2024-03-19 | Conversion (derivative) | 1,805 | $244.73 | 11,670 |
| 2024-03-19 | Open-market sale | 925 | $243.55 | 10,052 |
| 2024-03-19 | Grant / award | 1,805 | $0.00 | 10,977 |
| 2024-03-14 | Grant / award (derivative) | 1,601 | $240.97 | 13,475 |
| 2024-03-14 | Open-market sale | 2,736 | $240.16 | 9,172 |
| 2024-02-08 | Grant / award | 4,742 | $226.88 | 13,914 |
| 2024-02-08 | Open-market sale | 2,006 | $225.00 | 11,908 |
| 2024-01-04 | Open-market buy | 51 | $189.32 | 9,172 |
| 2023-07-10 | Open-market buy | 73 | $155.43 | 9,121 |
| 2023-03-21 | Conversion (derivative) | 2,018 | $0.00 | 11,848 |
| 2023-03-21 | Conversion | 875 | $171.05 | 9,048 |
| 2023-03-21 | Conversion | 2,018 | $0.00 | 9,923 |
| 2023-03-17 | Grant / award (derivative) | 2,164 | $0.00 | 13,866 |
| 2023-02-15 | Open-market sale | 1,525 | $169.41 | 7,905 |
| 2023-02-15 | Grant / award | 3,280 | $170.30 | 9,430 |
| 2023-01-04 | Grant / award | 80 | $141.46 | 6,150 |
| 2022-07-07 | Grant / award | 88 | $111.35 | 6,070 |
| 2022-03-17 | Grant / award (derivative) | 2,217 | $0.00 | 11,674 |
| 2022-03-15 | Conversion (derivative) | 952 | $0.00 | 9,457 |
| 2022-03-15 | Open-market sale | 435 | $144.66 | 5,982 |
| 2022-03-15 | Conversion | 952 | $144.85 | 6,417 |
| 2022-02-16 | Open-market sale | 530 | $137.23 | 5,465 |
| 2022-02-16 | Grant / award | 1,037 | $138.03 | 5,995 |
| 2022-01-06 | Grant / award | 84 | $117.82 | 4,958 |
| 2021-12-16 | Grant / award (derivative) | 5,660 | $0.00 | 10,383 |
| 2021-07-07 | Option exercise | 112 | $100.43 | 4,874 |
| 2021-03-18 | Grant / award (derivative) | 1,779 | $0.00 | 4,723 |
| 2021-03-16 | Open-market sale | 348 | $120.43 | 4,762 |
| 2021-03-15 | Conversion (derivative) | 732 | $0.00 | 2,944 |
| 2021-03-15 | Conversion | 732 | $123.49 | 5,110 |
| 2021-02-05 | Open-market sale | 477 | $113.37 | 4,378 |
| 2021-02-03 | Grant / award | 960 | $110.34 | 4,855 |
| 2021-01-07 | Option exercise | 110 | $98.62 | 3,895 |
| 2020-07-07 | Option exercise | 136 | $76.02 | 3,785 |
| 2020-02-06 | Open-market sale | 515 | $147.77 | 3,649 |
| 2020-02-05 | Grant / award | 989 | $147.61 | 4,164 |
| 2020-01-09 | Option exercise | 85 | $120.34 | 3,175 |
| 2019-11-19 | Conversion (derivative) | 566 | $141.12 | 1,665 |
| 2019-11-19 | Open-market sale | 299 | $140.00 | 3,090 |
| 2019-11-19 | Conversion | 566 | $141.12 | 3,389 |
| 2019-07-09 | Option exercise | 103 | $106.21 | 2,823 |
| 2019-02-07 | Grant / award | 1,312 | $116.16 | 3,375 |
| 2019-02-07 | Open-market sale | 655 | $114.96 | 2,720 |
| 2019-01-08 | Option exercise | 96 | $86.08 | 2,063 |
| 2018-11-26 | Open-market sale | 347 | $108.91 | 1,967 |
| 2018-11-23 | Option exercise (derivative) | 752 | $0.00 | 1,285 |
| 2018-11-23 | Option exercise | 752 | $107.59 | 2,314 |
| 2018-07-09 | Open-market buy | 110 | $101.71 | 1,562 |
| 2018-02-08 | Open-market sale | 700 | $120.25 | 1,452 |
| 2018-02-08 | Grant / award | 1,360 | $121.14 | 2,152 |
| 2018-01-09 | Open-market buy | 101 | $104.38 | 792 |
| 2017-11-16 | Option exercise (derivative) | 520 | $0.00 | 1,328 |
| 2017-11-14 | Option exercise | 520 | $117.74 | 885 |
| 2017-11-14 | Open-market sale | 194 | $117.94 | 691 |
| 2017-07-07 | Option exercise | 137 | $77.46 | 365 |
| 2017-01-13 | Grant / award | 154 | $83.95 | 228 |
| 2016-11-17 | Grant / award (derivative) | 558 | $0.00 | 1,838 |
| 2016-07-12 | Grant / award | 53 | $70.59 | 74 |
| 2016-01-14 | Grant / award | 21.25 | $58.84 | 21.25 |
| 2015-11-23 | Grant / award (derivative) | 740 | $0.00 | 1,250 |
| 2014-12-17 | Grant / award (derivative) | 510 | $0.00 | 510 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.